Evidence map›Paper›PMID 40621541›Full record

ArticlePakistan journal of medical sciences2025

Analysis of risk factors associated with Lymph Node Metastasis and Recurrence Post Thyroid Carcinoma Surgery.

Shengchao Wang, Zhongxu Bai, Huijuan Yan, Chunmei Yan, Junhui Wang

Abstract read
In one paragraph

Article in Pakistan journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shengchao WangShengchao Wang Department of Thyroid Surgery, Yellow River Sanmenxia Hospital, Sanmenxia 472000. Henan, Chian.
Zhongxu BaiZhongxu Bai Department of Orthopaedics, Zhengzhou Second Hospital, Zhengzhou 450052, Henan, China.
Huijuan YanHuijuan Yan Department of Gynecology, Yellow River Sanmenxia Hospital, Sanmenxia 472000. Henan, Chian.
Chunmei YanChunmei Yan Department of Hematology and Oncology, The 988th Hospital of the Joint Logistics Support Force, People's Liberation Army of China, Zhengzhou 450000, Henan, China.
Junhui WangJunhui Wang Department of Thyroid Surgery, Yellow River Sanmenxia Hospital, Sanmenxia 472000. Henan, Chian.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To investigate the risk factors associated with postoperative lymph node metastasis and recurrence in patients with thyroid carcinoma. Methods: Retrospective analysis of clinical data of one hundred patients with thyroid carcinoma who underwent first surgery at the Yellow River Sanmenxia Hospital from June 2019 to July 2023. Record postoperative lymph node metastasis, recurrence, and disease-free survival time. Kaplan Meier survival analysis was used to evaluate the recurrence free survival rate after surgery. Compared the differences between groups with and without lymph node metastasis. Analysis of risk factors for postoperative lymph node metastasis and recurrence in patients with thyroid carcinoma. Results: In study, 27 out of 100 patients experienced lymph node metastasis and recurrence, with an overall recurrence rate of 27.00%. There were nine cases of intrathyroid recurrence, 15 cases of cervical lymph node metastasis, two cases of intrathyroid metastasis with cervical lymph node metastasis, and one case of lung metastasis. Univariate analysis showed that gender, age, history of hyperthyroidism, tumor classification and staging, tumor diameter, number of cancer foci, unilateral or bilateral lesions, Conclusion: Gender, age, history of hyperthyroidism, tumor classification, tumor staging, and unilateral or bilateral lesions are independent risk factors for postoperative lymph node metastasis and recurrence in thyroid carcinoma.

Indexed as

Lymph node metastasisRecurrenceRisk factorsSurvival analysisThyroid carcinoma

Identifiers

PMID40621541
PMCPMC12223754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.